Fulcrum Therapeutics FULC
NASDAQ FULC
$3.69 +0.01 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Asset Writedowns and Impairment (2026)

Updated

Fulcrum Therapeutics' Asset Writedowns and Impairment was $5.09 million in Q2 2026.

Analysis

Fulcrum Therapeutics (FULC) Asset Writedowns and Impairment (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Fulcrum Therapeutics 281.49 Mn 281.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.09 Mn
API Access

Fulcrum Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=FULC&period=max&api_key=YOUR_API_KEY